VUNO Med-DeepBrain

VUNO Med-DeepBrain utilizes a deep learning algorithm to automatically segment and quantify brain structures and lesions from 3D T1 and 2D T2 FLAIR MR images, providing volumetric data and visualizations to aid clinicians. The software's methodology has demonstrated high accuracy and reproducibility in nonclinical testing, offering an automated alternative to manual image analysis for neuroimaging applications.

VUNO Med-DeepBrain is a medical image processing software designed for the automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions from MR images. It processes 3D T1 weighted and 2D T2 flair brain MR images to automate the identification and quantification tasks typically performed manually by trained healthcare professionals. The software provides outputs including segmented brain structures displayed with a color map, volumetric data for these regions, and lesion quantification, particularly from T2 flair images. It also allows comparison with normative percentile data and prior patient scans, and generates reports that can be integrated into Picture Archiving and Communication Systems (PACS) via the DICOM protocol. The core technology of VUNO Med-DeepBrain relies on a deep learning model, which distinguishes it from predicate devices that may use other machine learning techniques like multi-atlas segmentation. This model is trained to learn characteristics from a large dataset of MR images for automated segmentation, which includes 104 brain structures based on the FreeSurfer parcellation principle. Image pre-processing steps include size resampling, rigid registration, optional bias-field correction for T1 images, and brain extraction for T2 images, with post-processing involving outlier removal. Nonclinical performance testing demonstrated high segmentation accuracy, with Dice Similarity Coefficient scores exceeding 0.80 compared to expert segmentation for both brain regions and white matter hyperintensities. Volumetric error analysis for key structures like the hippocampus, thalamus, and lateral ventricle showed low relative (0.01-0.03 mm³) and absolute (140-377 mm³) errors, and test-retest reproducibility was excellent, with intraclass correlation coefficients above 0.965 for brain structures and 0.988 for WMH.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific deep learning architecture is employed by VUNO Med-DeepBrain, and how was its training dataset curated and validated for diversity and representativeness of various pathologies?; How does the software's performance in segmenting 104 structures, including two vessels, compare to the predicate's 133 structures, particularly in terms of clinical relevance and potential impact on diagnostic interpretations for specific neurological conditions?; Could the optional nature of bias-field correction significantly impact segmentation accuracy across different MRI scanner vendors or imaging protocols, and what guidance is provided to users for this option?; What are the specific details of the 'outlier removal' in the post-processing step, and how does it ensure that clinically relevant atypical findings are not inadvertently discarded?; Beyond the reported DSC scores and volume errors, how does the automated segmentation and quantification provided by VUNO Med-DeepBrain impact clinical workflow efficiency and inter-rater reliability compared to manual methods in real-world settings?